Novo Nordisk is currently leading the market for incretin therapies with semaglutide-based products Ozempic for type 2 ...

Professor Tim Spector has issued an urgent warning to people who may wish to take Ozempic "without a medical need". Ozempic ...

Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...

A new report finds half of adults in the United States could be eligible for popular weight loss drugs. KYW medical editor Dr ...

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but ...

Shares of Dr Reddy's Laboratories Ltd tumbled more than 6.65 per cent to Rs 1,203.60 on Friday, with its total market capitalisation slipping below Rs 1 lakh crore mark.

Dr Reddy’s shares tumbled up to 6% in early trade and at 9:46 am, they were trading 4.35% lower at Rs 1,233.25 on the Bombay Stock Exchange (BSE).

The House of Representatives passed a bill on Thursday to mandate doctors perform lifesaving care for babies born alive after abortion attempts. The search for two teens missing on Oahu's North Shore ...

Dr. Reddy’s is focusing on a pipeline of complex drugs, including GLP-1s (such as Semaglutide) as well as biosimilars and consumer care to offset the loss of exclusivity for its blockbuster drug ...

The long-term prospects for the company are evolving with product approvals in China, build-up of consumer healthcare franchise, and a biosimilar pipeline.

Revlimid, which has arguably been the single biggest growth driver for Dr Reddy's in recent years, is set to go off patent in ...

A viral video from a northeast Indianapolis gas station shows a man pointing a handgun in a woman's face and shoving her up against a car while threatening her. Police have since arrested the man on ...